首页|NF-κB信号通路在儿童支气管哮喘中的研究进展

NF-κB信号通路在儿童支气管哮喘中的研究进展

扫码查看
儿童支气管哮喘是一种以广泛气流受限为特征的慢性炎症性疾病,目前,其发病机制尚未清楚,可能涉及核因子κB(NF-κB)信号通路参与的炎症、免疫及气道重塑等因素。目前治疗主要以控制哮喘发作,延缓病情进一步发展为主,主要药物以激素等对症治疗为主,无法根治,对患儿产生严重影响,研究人员希望通过探讨NF-κB在儿童支气管哮喘具体发病机制,为临床诊断和治疗该病提供新的靶点,本文就NF-κB信号通路在儿童支气管哮喘发病中的机制进展做一综述,为后续研究提供理论指导。
Research progress of NF-κB signaling pathway in bronchial asthma in children
Childhood bronchial asthma is a chronic inflammatory disease characterized by extensive airflow obstruction.Currently,its pathogenesis is not yet clear and may involve inflammation,immunity,airway remodeling,etc.,involving nuclear factor-kappa B(NF-κB)signaling pathway.At present,the main treatment focus is on controlling asthma attacks and delaying the further development of the condition.The main drugs such as hormones etc.are used for symptomatic treatments,which cannot eradicate the disease and may have a serious impact on children.Researchers hope to provide a new target for clinical diagnosis and treatment of NF-κB by exploring the specific pathogenesis of bronchial asthma in children.This article reviews the mechanism of NF-κB signaling pathway in the pathogenesis of bronchial asthma in children,and provides theoretical guidance for subsequent studies.

Nuclear factor-kappa BSignaling pathwayBronchial asthmaChildren

赵改红、孙永红

展开 >

甘肃中医药大学第一临床医学院,甘肃兰州 730000

甘肃省人民医院儿科,甘肃兰州 730000

核因子κB 信号通路 支气管哮喘 儿童

甘肃省科技计划

20JR10RA385

2024

中国医药科学
海峡两岸医药卫生交流协会 二十一世纪联合创新(北京)医药科学研究院

中国医药科学

影响因子:1.083
ISSN:2095-0616
年,卷(期):2024.14(5)
  • 27